By: Steven F. Hotze, M.D.
Hotze Health & Wellness Center
The U.S. Senate is preparing to give the FDA the right to ban your bio-identical hormones. You need to act now to prevent this from happening.
You need to contact your Senators and Congressman today by going to the website www.mymedsmatter.com and send them an email, instructing them to oppose S.959. The provisions contained in S.959 give the FDA the authority to restrict and eliminate the bioidentical hormones upon which millions of women and men depend.
Five years ago, the FDA tried to ban the most commonly compounded bio-identical hormone treatments. The agency failed because it did not have the authority to do so, but S.959 would give the FDA the authority to do that and much more.
On May 22, 2013, the U.S. Senate Health, Energy, Labor and Pensions (HELP) Committee approved S.959, which would give FDA unprecedented control over compounding pharmacies and the medications upon which patients depend. Currently, all pharmacies, including compounding pharmacies, are under the jurisdiction of their respective state boards of pharmacy. Now the FDA wants to regulate compounding pharmacies and help Big Pharma by eliminating the competition of bio-identical hormones.
The U.S. Senate will vote on S.959 within the next 2 weeks, so you must act now to stop this bill from passing.
S.959 is in response to a tragedy caused by contaminated injections distributed by New England Compounding Center (NECC), which had no connection with bio-identical hormones. The FDA already has the authority to prevent the recurrence of that tragedy, but Big Pharma is using this as an excuse to eliminate competition by compounding pharmacies that do not even sell such injections.
Now, having proved itself incompetent in dealing with the NECC, the FDA wants to expand its jurisdiction over thousands of compounding pharmacies which ultimately will lead to banning bio-identical hormones and other compounded medications upon which millions of patients rely.
Continue Reading at: Hotze Health & Wellness Center
